Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
Aandelen, abnormal, Aktiengesellschaft, Annex, ARB, attempt, belief, Biomedical, Biosafety, BioSprint, bioterrorism, Bloodbourne, Boerse, bond, broader, broadest, Chester, Circle, Clarification, clearance, composed, concede, Connecticut, consecutive, contingency, contingent, coupon, Creation, crime, criterion, cRNA, curtail, deceased, default, depletion, DHL, diligence, Displacement, distributor, downturn, expenditure, FIN, Fisher, forward, Foundation, fractionation, fragmentation, GMO, great, Haven, Hazard, idle, Indenture, interrupted, intrinsic, inventor, IvDD, Karobathstudied, MDA, MDxDSP, membership, milestone, MSI, multiplied, multiplying, NYSE, OBI, OSHA, overcoming, Oversight, paragraph, partly, phone, Preferente, proteomic, QGEN, Qproteome, RCAT, realign, realigned, realignment, reappointed, reassessment, refinance, refocused, regime, reliance, repaid, repay, repurchase, rest, retail, revaluation, Rolling, scarce, Schatzjoined, smallest, SPAQ, spoilage, stand, sustain, threat, TMO, travel, Trustee, unanimity, unsubordinated, violation, vulnerable, warrant, WGA
Removed:
activated, actively, adsorb, affiliated, Alameda, alliance, ambion, America, analyzed, answer, antidilutive, applicability, arm, arrayable, assay, assignment, auditing, automatable, automate, bacterial, BD, begin, bind, biopharmaceutical, blend, blueprint, Boom, borrow, Borse, break, breakthrough, broken, buffer, bulk, bundle, bundled, capability, capable, capitalization, capture, CARDION, carryforward, carryover, cationic, ceased, cellular, cellulose, cerevisiae, Chain, chelate, chelating, CHF, choose, chosen, chromatography, circular, clearing, Cleavable, cleaving, clinically, cm, coated, coli, collected, collecting, column, combated, combine, combined, combining, commenced, commercialize, comparison, comprise, consortium, consultative, consuming, contact, contaminating, convenient, convey, copied, covering, CpG, CRM, crude, culture, cultured, cured, cycler, degradation, degraded, dendrimer, design, destroy, detergent, directional, discussion, disrupt, disseminating, diversify, donated, drawn, DSM, dynamic, easier, easily, economical, edge, edition, effectene, Ehrlich, elution, emphasize, employing, Empore, encoded, encompassing, endofree, endotoxin, enhanced, enhancement, enhancing, enzymatic, EPICEPT, eventually, exchanged, excluding, exponentially, extension, extremely, falciparum, faster, fastest, feedback, filtered, filtration, Fine, flexible, fluorescence, format, formation, formulated, formulation, fragile, frequently, fueled, GeneMedicine, govern, Green, harbor, hardware, harvested, Haserjian, HCV, HiSpeed, Histidine, historic, hormone, HotStarTaq, HS, hundred, hybrid, hybridization, ideal, immunization, immunoassay, improvement, inclusion, Indemnity, induce, induced, induction, inexpensive, influenza, initiated, initiative, insect, insertion, insoluble, insulin, intact, integrity, interaction, interferon, involving, Iowa, isolate, isolated, Jersey, labeling, larger, LCx, leveraged, LIBOR, ligand, linear, link, lipid, living, longmer, lysate, maintaining, mammalian, man, marginal, Masscode, massive, mechanically, melanogaster, membrane, metal, microinjection, miniprep, modifying, moving, mRNA, mutation, Mycobacterium, NTA, nucleotide, OEM, oligonucleotide, Oligotex, Omniscript, OneStep, open, optimization, optimize, optimized, Orchid, Organon, overhead, Overview, Pall, pAlliance, patented, Paul, penetrate, PerkinElmer, pertaining, phase, piece, plasma, Plasmodium, platform, PolyFect, polymerase, pooling, poor, popular, powerful, prepare, prerequisite, preservation, prevention, priced, primer, probe, procedure, productivity, profiling, prominently, promote, promoting, protected, protective, pure, purifying, QIAEX, QIAfilter, QIAprecipitator, QIAprep, QIAquick, QIAwell, quantification, RADIOMETER, RapidPlate, Rapigene, rat, realization, Realty, recombination, recommendation, recovering, recurring, Reform, regulating, removal, renamed, reproducibility, reproduction, reputation, resin, resonance, restricted, reversed, revolutionary, Richard, RLS, RNAlater, robotic, room, routine, RT, safe, safely, scattering, screening, selectively, SensiChip, Sensiscript, Sequenom, serum, shift, Sigma, signal, situated, sizeable, skill, smaller, SNP, soluble, Spectrometry, spread, stabilize, stabilizing, Stolberg, stored, structural, studied, Sugarman, suitable, SuperFect, surface, SYBR, synergistic, synergy, tag, tagged, tagging, tailored, targeted, technique, Teknika, temperature, template, terminated, thousand, tightly, tip, today, Tokyo, toxic, toxicology, trace, tracking, transcribed, transcribing, transcriptase, transfecting, TransMessenger, transported, TruPrepTM, TurboFilter, UA, ultrapurity, understand, understanding, uniquely, unparalleled, unstable, unsurpassed, vaccine, vacuum, validation, varying, vector, VGI, Visible, warehouse, washed, washing, Wave, workstation, yeast
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.1 Credit Contract for a Club Deal Between Qiagen & Deutsche Bank
- 2.2 Declaration by Qiagen N.V. to Deutsche Bank
- 2.3 Indenture Between Qiagen Finance S.a., Qiagen N.V. and Deutsche Bank
- 2.4 Agreement In Connection with the Delivery of Ordinary Shares
- 4.14 Letter Between Qiagen and DR. Joachim Schorr, Dated March 24, 2003
- 4.15 Letter Between Qiagen and DR. Joachim Schorr, Dated October 9, 2003
- 4.17 Letter Between Qiagen and Bernd Uder, Dated October 9,2003
- 4.18 Letter Between Qiagen and Bernd Uder Clarification, Dated October 9, 2003
- 4.19 Employment Agreement by and Between Qiagen and Roland Sackers, Dated 01/01/04
- 4.20 Employment Agreement by and Between Qiagen and Roland Sackers, Dated 01/05/04
- 4.21 Change of Control Agreement Between Qiagen and Roland Sackers, As of 09/30/03
- 4.22 Empolyment Agreement by and Between Qiagen N.V.& Roland Sackers, Dated 08/05/04
- 4.23 Consultancy Agreement Between Qiagen and DR. Metin Colpan, Dated 12/04/03
- 4.24 Letter Between Qiagen and Peer Schatz, Dated 10/09/03
- 8.1 List of Subsidiaries
- 12.1 Certifications Under Section 302; Peer Schatz, CEO
- 12.2 Certifications Under 302; Roland Sackers, CFO
- 13.1 Certifications Under Section 906; Peer Schatz, CEO and Roland Sackers, CFO
- 15.1 Consent of Ernst & Young LLP
QGEN similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-107491 and 333-7166) pertaining to the QIAGEN N.V. 1996 Employee, Director and Consultant Stock Option Plan of our report dated February 11, 2005, with respect to the consolidated financial statements and schedule of QIAGEN N.V. included in the Annual Report (Form 20-F) for the year ended December 31, 2004.
/s/ Ernst & Young LLP
McLean, Virginia
April 14, 2005